Encephalomyelitis associated with coronavirus disease 2019: a case report코로나바이러스 질병 2019와 관련된 뇌척수염: 사례 보고Case Reports Published on 2022-08-232022-09-12 Journal: Journal of Medical Case Reports [Category] 진단, [키워드] acute respiratory syndrome administration antibody article Asian Case report cerebrospinal fluid clinical Clinical improvement coronavirus coronavirus disease COVID-19 Deterioration diagnosed discharge DNA effective Encephalitis Encephalomyelitis female Fever high-dose methylprednisolone immunomodulator Infection Intravenous immunoglobulin Longitudinally extensive transverse myelitis. Loss of consciousness Manifestations Mild neurological neurological manifestation presenting steroid Symptoms the patient Treatment [DOI] 10.1186/s13256-022-03539-9 PMC 바로가기 [Article Type] Case Reports
A Case Report for Using Methylprednisolone for Severe ARDS Caused by SARS-CoV-2 Delta Variant in a Pediatric Patient With Lennox-Gastaut SyndromeLennox-Gastaut 증후군이 있는 소아 환자에서 SARS-CoV-2 Delta 변이로 인한 중증 ARDS에 대한 Methylprednisolone 사용에 대한 증례 보고서Case Reports Published on 2022-03-142022-09-11 Journal: Journal of Korean medical science [Category] SARS, 변종, [키워드] acute respiratory distress acute respiratory distress syndrome acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Administered ARDS B.1.617.2 caused children Comorbidities Comorbidity coronavirus coronavirus disease Coronavirus disease 2019 Coronavirus disease-19 Coronavirus disease-19 (COVID-19) COVID-19 Delta End-Expiratory Pressure Expiratory Pressure extubation Fever high fever high-dose methylprednisolone hospital increased risk intractable Lennox-Gastaut Syndrome Methylprednisolone neurologic observation Oxygenation pandemic Pediatric patient Pediatric patients Positive end-expiratory pressure report reported required respiratory respiratory distress Respiratory distress syndrome SARS-CoV-2 SARS-CoV-2 delta Seizure Seizures severe acute respiratory syndrome Coronavirus severe ARDS Severe case severe cases severe COVID-19 syndrome the SARS-CoV-2 Tidal volume Treatment variant Volume [DOI] 10.3346/jkms.2022.37.e82 PMC 바로가기 [Article Type] Case Reports
COVID-19-associated necrotizing encephalopathy presenting without active respiratory symptoms: a case report with histopathology활동성 호흡기 증상이 없는 코로나19 관련 괴사성 뇌병증: 조직병리학 증례 보고Case Reports Published on 2022-02-012022-09-11 Journal: Journal of Neurovirology [Category] COVID19(2023년), SARS, 유전자 메커니즘, 치료기술, [키워드] absence acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Analysis Aphasia Atypical Case report cerebrospinal fluid characteristic coronavirus coronavirus disease Coronavirus disease 2019 Course COVID-19 described detect diagnosed Diagnosis diagnostic Encephalopathy etiologies exclusion expressive expressive aphasia feature hemorrhage high-dose methylprednisolone Histopathology Infection Inflammation lesion Methylprednisolone Mild MRI Necrosis neutrophilic Next-generation sequencing nucleic acids outcome pathogenic Patient perivascular pleocytosis Presence presenting respiratory symptoms SARS-CoV-2 secondary to serology severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 small vessel Symptoms treated Vasculitis viral respiratory [DOI] 10.1007/s13365-021-01042-3 PMC 바로가기 [Article Type] Case Reports
Macrophage activation syndrome in MDA5 antibody-positive dermatomyositis and COVID-19 infectionCase Report Published on 2021-12-132022-10-28 Journal: BMC Rheumatology [Category] COVID-19, [키워드] activating Activation association clinically Coronavirus disease 2019 COVID-19 COVID-19 infection Cytokine storm dermatomyositis diagnosed Diagnosis disease Diseases disorder erythematous fatal complication female high-dose methylprednisolone highlight hyperinflammatory state immune system Intravenous immunoglobulin joint macrophage activation syndrome MDA5 Melanoma Multiorgan Protein Rash rheumatological Shortness of breath syndrome weakness weight loss [DOI] 10.1186/s41927-021-00225-z PMC 바로가기 [Article Type] Case Report
Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia코비드-19 폐렴에 대한 덱사메타손 대 메틸프레드니솔론 고용량Randomized Controlled Trial Published on 2021-05-252022-08-13 Journal: PLoS ONE [Category] Biochemistry, MERS, SARS, 임상, [키워드] acute respiratory syndrome Administered alveolar pressure Ambispective cohort study Analysis applied ARDS Berlin protocol C-reactive protein calculated can be used carried Chain Reaction Chest Chest tomography clinic Clinical outcome completion coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 Corticosteroid COVID-19 pneumonia CRP D-dimer decrease Dexamethasone dexamethasone 6 mg DHL diagnosed discharge dose DXM effective therapy evaluated Follow-up followed by ground-glass imaging High dose high-complexity clinic high-dose methylprednisolone Hospitalization Hospitalized hospitalized patient hospitalized patients inclusion criteria Infectious disease Infectious diseases inspired oxygen fraction institutional protocol intensive care intensive care unit intravenous Invasive mechanical ventilation Laboratory laboratory result Laboratory results LDH less living-dead status marker material Medellín, Colombia Methylprednisolone Mortality MTP group Not applied optimal dose outpatient consultation oxygen P-value PaFi Patient patients treated Pneumonia polymerase chain polymerase chain reaction Prednisone proportion prospective cohort protocol Pulmonology radiological Randomized controlled studies readmission Recovery time required responsible Result Sample Sample size SARS-CoV2 Seven Severe acute respiratory syndrome severe ARDS Severe COVID-19 pneumonia severe SARS severity shown significantly statistically subsequent supplementary oxygen survival survival analysis telephone the patient tomography total population transfer treated Treatment [DOI] 10.1371/journal.pone.0252057 PMC 바로가기 [Article Type] Randomized Controlled Trial
Paediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 [PIMS-TS] in a Patient Receiving Infliximab Therapy for Inflammatory Bowel Disease염증성 장 질환에 대해 인플릭시맙 요법을 받는 환자에서 SARS-CoV-2[PIMS-TS]와 일시적으로 연관된 소아 염증성 다계통 증후군Case Reports Published on 2021-04-062022-09-12 Journal: Journal of Crohn's & colitis [Category] MERS, 진단, [키워드] Alpha Analysis Bone marrow bowel C-reactive protein Cell clinical phenotype Course current D-dimer described diagnose elevated erythrocyte sedimentation rate Extensive Fever Follow-up high-dose methylprednisolone hyperinflammation immune response Inflammatory Inflammatory bowel disease infliximab Intravenous immunoglobulin lactate dehydrogenase Necrosis occur Organ failure paediatric Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 [PIMS-TS] Patient polymerase chain reaction Pyrexia raised remained renal SARS-CoV-2 serology Shock Support syndrome the disease the patient therapeutic strategy therapy treated Treatment ulcerative colitis white cell [DOI] 10.1093/ecco-jcc/jjaa201 PMC 바로가기 [Article Type] Case Reports
Subacute cerebellar ataxia following respiratory symptoms of COVID-19: a case reportCase Report Published on 2021-03-242022-10-28 Journal: BMC Infectious Diseases [Category] COVID-19, [키워드] absence acute respiratory syndrome Anosmia/ageusia antibody production assumed Ataxia Atypical Autoimmune Case report cause cell count cerebral cerebrospinal fluid Clinical finding clinician Coronavirus disease 2019 corticosteroid treatment COVID-19 described disease Dizziness excluded fatigue Fever headache High-dose high-dose methylprednisolone Immune-mediated Laboratory less magnetic resonance imaging mechanism Mild Miller fisher syndrome neurological Neurological deficit Neurological symptom occur Other Post-infectious cerebellar ataxia Post-infectious neurological disease respiratory symptom respiratory symptoms SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 RNA Seizures Subacute symptomatic SARS-CoV-2 infection syndrome therapy upper airways viral infections virus [DOI] 10.1186/s12879-021-05987-y PMC 바로가기 [Article Type] Case Report
Pulse Therapy With Corticosteroids and Intravenous Immunoglobulin in the Management of Severe Tocilizumab-Resistant COVID-19: A Report of Three Clinical CasesEmergency Medicine Published on 2020-07-072022-10-31 Journal: Cureus [Category] COVID-19, [키워드] changes clinical clinical manifestation Combination Corticosteroids COVID-19 CRS Cytokine release syndrome Efficacy and safety Evidence high-dose methylprednisolone Immunoglobulin intravenously life-threatening life-threatening coronavirus disease Methylprednisolone Patient patients persistence pulmonary CT pulse pulse therapy Randomized controlled trial report required Respiratory failure Safe SARS-CoV-2 therapy Treatment treatment regimen virus [DOI] 10.7759/cureus.9038 PMC 바로가기 [Article Type] Emergency Medicine